Andrea Idili

Andrea Idili

Auto-generated profile, based on publicly available information

Andrea Idili

Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via Della Ricerca Scientifica, Rome 00133, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2014 in Journal of the American Chemical Society
Verified
Journal Article
Open access
AIAndrea Idili
Andrea Idili
AVAlexis Vallée-Bélisle
Alexis Vallée-Bélisle
FRFrancesco Ricci
Francesco Ricci
We have designed programmable DNA-based nanoswitches whose closing/opening can be triggered over specific different pH windows. These nanoswitches form an intramolecular triplex DNA structure through pH-sensitive parallel Hoogsteen interactions. We demonstrate that by simply changing the relative content of TAT/CGC triplets in the switches, we can rationally tune their pH dependence over more than 5 pH units. The ability to design DNA-based switches with tunable pH dependence provides the opportunity to engineer pH nanosensors with unprecedented wide sensitivity to pH changes. For example, by mixing in the same solution three switches with different pH sensitivity, we developed a pH nanosensor that can precisely monitor pH variations over 5.5 units of pH. With their fast response time (<200 ms) and high reversibility, these pH-triggered nanoswitches appear particularly suitable for applications ranging from the real-time monitoring of pH changes in vivo to the development of pH sensitive smart nanomaterials.

8 November 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
YHYuwei Hu
Yuwei Hu
Alessandro CecconelloAlessandro Cecconello
Alessandro Cecconello
AIAndrea Idili
Andrea Idili
FRFrancesco Ricci
Francesco Ricci
Itamar WillnerItamar Willner
Itamar Willner

7 April 2017 in Science Advances
Verified
Journal Article
Open access
PDF file
AKAnton Kuzyk
Anton Kuzyk
MUMaximilian J. Urban
Maximilian J. Urban
AIAndrea Idili
Andrea Idili
FRFrancesco Ricci
Francesco Ricci
NLNa Liu
Na Liu
DNA origami nanotechnology enables selective reconfiguration of plasmonic quasi-enantiomers through simple pH tuning.

10 August 2021 in ACS Sensors
Verified
Journal Article
Open access
AIAndrea Idili
Andrea Idili
CPClaudio Parolo
Claudio Parolo
RARuslán Alvarez-Diduk
Ruslán Alvarez-Diduk
Arben MerkoçiArben Merkoçi
Arben Merkoçi
The availability of sensors able to rapidly detect SARS-CoV-2 directly in biological fluids in a single step would allow performing massive diagnostic testing to track in real time and contain the spread of COVID-19. Motivated by this, here, we developed an electrochemical aptamer-based (EAB) sensor able to achieve the rapid, reagentless, and quantitative measurement of the SARS-CoV-2 spike (S) protein. First, we demonstrated the ability of the selected aptamer to undergo a binding-induced conformational change in the presence of its target using fluorescence spectroscopy. Then, we engineered the aptamer to work as a bioreceptor in the EAB platform and we demonstrated its sensitivity and specificity. Finally, to demonstrate the clinical potential of the sensor, we tested it directly in biological fluids (serum and artificial saliva), achieving the rapid (minutes) and single-step detection of the S protein in its clinical range.

22 July 2019 in Chemical Science
Verified
Journal Article
Open access
PDF file
AIAndrea Idili
Andrea Idili
NANetzahualcóyotl Arroyo-Currás
Netzahualcóyotl Arroyo-Currás
KPKyle L. Ploense
Kyle L. Ploense
ACAndrew T. Csordas
Andrew T. Csordas
MKMasayasu Kuwahara
Masayasu Kuwahara
KPKevin Plaxco
Kevin Plaxco
The ability to measure drugs in the body rapidly and in real time would advance both our understanding of pharmacokinetics and our ability to optimally dose and deliver pharmacological therapies. To this end, we are developing electrochemical aptamer-based (E-AB) sensors, a seconds-resolved platform technology that, as critical for performing measurements in vivo, is reagentless, reversible, and selective enough to work when placed directly in bodily fluids. Here we describe the development of an E-AB sensor against irinotecan, a member of the camptothecin family of cancer chemotherapeutics, and its adaptation to in vivo sensing. To achieve this we first re-engineered (via truncation) a previously reported DNA aptamer against the camptothecins to support high-gain E-AB signaling. We then co-deposited the modified aptamer with an unstructured, redox-reporter-modified DNA sequence whose output was independent of target concentration, rendering the sensor's signal gain a sufficiently strong function of square-wave frequency to support kinetic-differential-measurement drift correction. The resultant, 200 μm-diameter, 3 mm-long sensor achieves 20 s-resolved, multi-hour measurements of plasma irinotecan when emplaced in the jugular veins of live rats, thus providing an unprecedentedly high-precision view into the pharmacokinetics of this class of chemotherapeutics.

8 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
SRSimona Ranallo
Simona Ranallo
CPCarl Prévost-Tremblay
Carl Prévost-Tremblay
AIAndrea Idili
Andrea Idili
AVAlexis Vallée-Bélisle
Alexis Vallée-Bélisle
FRFrancesco Ricci
Francesco Ricci
A wide range of molecular devices with nanoscale dimensions have been recently designed to perform a variety of functions in response to specific molecular inputs. Only limited examples, however, utilize antibodies as regulatory inputs. In response to this, here we report the rational design of a modular DNA-based nanomachine that can reversibly load and release a molecular cargo on binding to a specific antibody. We show here that, by using three different antigens (including one relevant to HIV), it is possible to design different DNA nanomachines regulated by their targeting antibody in a rapid, versatile and highly specific manner. The antibody-powered DNA nanomachines we have developed here may thus be useful in applications like controlled drug-release, point-of-care diagnostics andin vivoimaging.